Harbor Investment Advisory’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
AIM
EB
JWM
SC
MSV
TFA
CNB
MPWT
ZCI
Harbor Investment Advisory's DGX Position: Q3 2026 in Review
Harbor Investment Advisory increased its Quest Diagnostics (DGX) stake by 16% in Q3 2026, buying an estimated $4.39K and bringing the position to 135 shares worth $31.5K. The position accounts for ﹤0.01% of the portfolio, ranked #868.
Harbor Investment Advisory first reported a position in DGX in Q4 2019 and has held it in 28 quarters since. The position peaked at $276K in Q2 2020. 62 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Harbor Investment Advisory held 135 shares of Quest Diagnostics worth $31.5K as of Q3 2026.
- Harbor Investment Advisory bought 19 Quest Diagnostics shares in Q3 2026, an estimated $4.39K.
- Quest Diagnostics made up ﹤0.01% of Harbor Investment Advisory's portfolio in Q3 2026, its #868 holding.
- Harbor Investment Advisory first reported a position in Quest Diagnostics in Q4 2019 and has held it in 28 quarters since.
- Harbor Investment Advisory's Quest Diagnostics position peaked at $276K in Q2 2020.
- 62 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Harbor Investment Advisory's 13F filing for Q3 2026, filed 13 Oct 2026.